SYNTHESIS AND EVALUATION OF THE ANTIPROLIFERATIVE EFFECTS OF TAMIDO-2'-DEOXY-BETA-D-GLUCOPYRANOSYL)-SN-GLYCEROL AND -AMINO-2'-DEOXY-BETA-D-GLUCOPYRANOSYL)-SN-GLYCEROL AN EPITHELIAL CANCER CELL-GROWTH

Citation
Rk. Erukulla et al., SYNTHESIS AND EVALUATION OF THE ANTIPROLIFERATIVE EFFECTS OF TAMIDO-2'-DEOXY-BETA-D-GLUCOPYRANOSYL)-SN-GLYCEROL AND -AMINO-2'-DEOXY-BETA-D-GLUCOPYRANOSYL)-SN-GLYCEROL AN EPITHELIAL CANCER CELL-GROWTH, Journal of medicinal chemistry, 39(7), 1996, pp. 1545-1548
Citations number
11
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
39
Issue
7
Year of publication
1996
Pages
1545 - 1548
Database
ISI
SICI code
0022-2623(1996)39:7<1545:SAEOTA>2.0.ZU;2-X
Abstract
Two ether glucosyl diglyceride analogs were synthesized, and their ant iproliferative activity against four epithelial cancer cell lines was evaluated. -3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl) -sn-glyc erol (4) was synthe sized by reaction of 2-acetamido-2-deoxy-3, 4,6-tr i-O-acetyl-alpha-D-glucopyranosyl chloride with 1-O-hexadecyl-2-O-meth yl-sn-glycerol followed by deacetylation by methanolic hydrolysis. The N-acetyl group of 4 was removed by hydrolysis with ethanolic potassiu m hydroxide to form thyl-3-O-(2'-amino-2'-deoxy-beta-D-glucopyranosyl) -sn-glycerol (5). Compounds 4 and 5 inhibited the proliferation of MC F-7, A549, A427, and T84 cancer cell lines. The IC50 values for 5 rang ed from 6.5 to 12.2 mu M, whereas 4 was more effective against A549 ce lls (IC50 9 mu M) than against MCF-7 (IC50 17 mu M) and A427 (IC50 25 mu M) cells and was inactive against T84 cells. Under identical incuba tion conditions, compounds 4 and 5 were potent inhibitors of the proli feration of OVCAR-3 cells with IC50 values of 12 and 4 mu M, respectiv ely, whereas ET-18-OCH3, hexadecylphosphocholine, and erucylphosphocho line had IC50 values of 24, >30, and >30 mu M, respectively. The cell- inhibitory profile of these ether-linked glucosyl diglycerides strengt hens the hypothesis that such glycolipids represent a distinct group o f antitumor ether lipids, having antineoplastic activities that differ from the well-known alkylphosphocholines and alkyllysophospholipids.